Black Diamond Therapeutics, Inc. (BDTX)
1.805
-0.14
(-6.96%)
USD |
NASDAQ |
Oct 06, 16:00
1.805
0.00 (0.00%)
After-Hours: 17:43
Black Diamond Therapeutics Price to Book Value : 1.079 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 1.160 |
| October 02, 2026 | 1.130 |
| October 01, 2026 | 1.124 |
| September 30, 2026 | 1.127 |
| September 29, 2026 | 1.118 |
| September 28, 2026 | 1.094 |
| September 25, 2026 | 1.124 |
| September 24, 2026 | 1.130 |
| September 23, 2026 | 1.136 |
| September 22, 2026 | 1.184 |
| September 21, 2026 | 1.166 |
| September 18, 2026 | 1.172 |
| September 17, 2026 | 1.154 |
| September 16, 2026 | 1.160 |
| September 15, 2026 | 1.178 |
| September 14, 2026 | 1.214 |
| September 11, 2026 | 1.184 |
| September 10, 2026 | 1.172 |
| September 09, 2026 | 1.255 |
| September 08, 2026 | 1.255 |
| September 04, 2026 | 1.267 |
| September 03, 2026 | 1.255 |
| September 02, 2026 | 1.279 |
| September 01, 2026 | 1.220 |
| August 31, 2026 | 1.255 |
| Date | Value |
|---|---|
| August 28, 2026 | 1.333 |
| August 27, 2026 | 1.357 |
| August 26, 2026 | 1.357 |
| August 25, 2026 | 1.339 |
| August 24, 2026 | 1.288 |
| August 21, 2026 | 1.321 |
| August 20, 2026 | 1.285 |
| August 19, 2026 | 1.309 |
| August 18, 2026 | 1.232 |
| August 17, 2026 | 1.226 |
| August 14, 2026 | 1.208 |
| August 13, 2026 | 1.208 |
| August 12, 2026 | 1.255 |
| August 11, 2026 | 1.250 |
| August 10, 2026 | 1.184 |
| August 07, 2026 | 1.166 |
| August 06, 2026 | 1.148 |
| August 05, 2026 | 1.070 |
| August 04, 2026 | 1.064 |
| August 03, 2026 | 1.037 |
| July 31, 2026 | 1.010 |
| July 30, 2026 | 1.025 |
| July 29, 2026 | 0.9924 |
| July 28, 2026 | 1.052 |
| July 27, 2026 | 1.034 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.63 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.281 |
| Curis, Inc. | 0.3131 |
Price to Book Value Related Metrics
| Price | 1.805 |
| Earnings Yield | -41.26% |
| Market Cap | 103.69M |